Vitamin D Supplementation for the Prevention of Acute Respiratory Infections: a RCT in Young Finnish Men

NCT05014048 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 231

Last updated 2023-10-18

No results posted yet for this study

Summary

Vitamin D intervention effects on the prevention of acute respiratory tract infections among Young Finnish Men

Conditions

  • Vitamin D Deficiency
  • Respiratory Tract Infections

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

20 mikrog vitamin D3 daily

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Finnish Defense Forces

    collaborator OTHER_GOV
  • Tampere University

    lead OTHER

Principal Investigators

  • ilkka laaksi, MDPhD · University of Tampere, Finland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-04
Primary Completion
2018-05-14
Completion
2018-05-14

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05014048 on ClinicalTrials.gov